Your medical device start-up has fantastic potential, but it’s essential to make the right decisions today to maximise its value in the future and make it attractive to investors and/or potential buyers. That means finding the right partners to progress your idea. Running a start-up medical device company is an exciting but often very busy … How Arrotek Adds Value to Your Medical Device Start-Up Company
By Richard McLoughlin Bringing a new medical device product to market is an intensive and extensive process, so it’s important you get the right support. The best approach is to work with a partner that offers a complete service offering, with end-to-end support from the concept development stage through to full-scale manufacturing. At Arrotek, we … Medical Device Design Services – Support from Concept to Full-Scale Production
Arrotek has been named as one of two finalists for the MedTech Company of the Year Award at the Irish MedTech Awards 2022. The Irish MedTech Awards are run by the Irish MedTech Association, Enterprise Ireland, and IDA Ireland. The MedTech Company of the Year Award is one of nine awards that will be announced … Arrotek Shortlisted for MedTech Company of the Year 2022
Arrotek Medical has opened a new office in Massachusetts, USA. The office is part of our strategic growth plans and will enhance the service we offer to our growing client base in the US and Canada. Richard McLoughlin, Sales and Marketing Manager at Arrotek, said: “The United States has been an important market for us … Arrotek Medical Opens US Office
By Paula Johnson While fine needle aspiration (FNA) and fine needle biopsy (FNB) are common procedures for the diagnosis of cancer, there is no specific device option that is the best choice in all situations. In fact, there is a large range of design and feature options available in both the FNA and FNB categories … Choosing the Right Fine Needle Aspiration or Fine Needle Biopsy Device
Design transfer is a phrase that describes the activities and processes that introduce a medical device design to production. Effective design transfer is required by regulators but it also keeps manufacturing costs under control and ensures production milestones and deadlines are met. Furthermore, effective design transfer can reduce time to market and improve product quality. What … Three-Phase Design Transfer Process to Prepare a Design for Manufacturing
Our modular approach to the delivery of medical device design and development services means we can help with whatever level of support you need, whatever expertise you need, and wherever you are in the development process. While there are similarities across all medical device design and development projects, our experience at Arrotek is that every … Arrotek’s Modular Approach to Medical Device Design and Development Services
It is now over a year since the new EU Medical Device Regulation (MDR) came into effect. Whether you are an early-stage start-up, a company further advanced in your start-up journey, or an established medical device company, what are the current realities of EU MDR compliance? The fact is, there are challenges that will impact … Bottlenecks, Timelines, and Complexity: Overcoming EU MDR Challenges
Arrotek is delighted to be a finalist in three award categories at tonight’s Irish Manufacturing and Supply Chain awards 2022. The awards we are up for are: Congratulations to the other finalists in our award categories, as well as all the finalists for other awards. The winners are being announced at a ceremony in the … Arrotek Delighted to be Finalists at Tonight’s Irish Manufacturing and Supply Chain awards 2022
By Richard McLoughlin Supply chain resilience is currently a priority topic for companies in a range of industries, and MedTech is no different. Many factors are contributing to this enhanced focus on supply chain resilience, not least the experiences of medical device companies, patients, and customers during the Covid-19 pandemic. It’s not just companies, either, … Is Your Medical Device Supply Chain as Resilient as You’d Like it to Be?
